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Abstract 
People with diabetes have an increased risk of developing several serious health 
problems. One of the most frequent complication is an impaired wound healing. 
Neutrophils are recruited early to the wound bed and, upon activation, they undergo 
histone citrullination by protein arginine deiminase (PAD)4, exocytosis of chromatin and 
enzymes as neutrophil extracellular traps (NETs), and death. This process is called 
NETosis. In diabetes, neutrophils are primed to release NETs and die by NETosis. 
Although this process is a defense against infection, excessive NETosis can damage 
tissue. 
The aim of this study was to examine the effect of NETosis on the healing of diabetic 
foot ulcers (DFUs). Using proteomics, we found that NET components were enriched in 
non-healing human DFUs. In an independent validation cohort, a high concentration of 
neutrophil elastase in the wound was associated with infection and a subsequent 
worsening of the ulcer. NET components were elevated in the blood of patients with 
DFUs. Neutrophils isolated from the blood of DFU patients showed an increased 
spontaneous NETosis, but an impaired inducible NETosis. We have set up a system of 
intravital microscopy to monitor the presence of neutrophils in a mouse model of ulcer; 
this imaging technique, in addition to FACS detection of histone citrullination, showed 
that (1) PAD4 activity was increased by diabetes and (2) NETosis occurred in the bed of 
excisional wounds. 
PAD4 inhibition by Cl-amidine reduced NETting neutrophils and rescued wound healing 
in diabetic mice. Cumulatively, these data suggest that NETosis delays DFU healing and 
its modulation could be a therapeutic strategy to improve outcome of DFU in diabetic 
patients.  
Riassunto 
La FID, Federazione Internazionale del Diabete, paragona questa patologia ad una vera e 
propria epidemia inarrestabile. Una delle gravi complicanze causata da questa malattia 
sono le ulcere nel piede del diabetico (DFU, Diabetic Foot Ulcer): infatti la guarigione 
delle ferite è compromessa in molti pazienti diabetici e ciò provoca un aumentato 
rischio di morbilità e mortalità. 
I neutrofili sono le principali cellule coinvolte nelle prime fasi della guarigione delle 
ulcere, in quanto sono la principale componente cellulare reclutata in sede di danno 
tissutale. I neutrofili hanno un ruolo fondamentale nel sistema immunitario innato e 
rappresentano la prima difesa contro l’infezione da patogeni. Questa attività 
antimicrobica è resa possibile anche da un tipo di morte cellulare tipico dei neutrofili al 
quale è stato dato il nome di NETosi. La NETosi si differenzia da necrosi, apoptosi, 
necroptosi e autofagia. E’ innescata da PAD4 (Peptidil Arginine Deaminase 4) che è un 
enzima nucleare Ca2+-dipendente appartenente alla superfamiglia delle 
amidinotransferasi, coinvolto nella citrullinazione degli istoni. A questa fase seguono la 
decondensazione della cromatina, la migrazione dell’elastasi all’interno del nucleo e la 
rottura della membrana nucleare con il conseguente rilascio di DNA sottoforma di 
filamenti. Questi filamenti, chiamati NETs (Neutrophil Extracellular Traps), sono 
composti da enzimi e proteine granulari e da materiale nucleare, il cui compito è quello 
di intrappolare fisicamente i patogeni e le loro componenti, fino alla lisi cellulare. Questo 
processo è alterato nel diabete e può provocare danni ai tessuti, causando un ritardo 
nella guarigione delle ferite. 
Lo scopo di questo progetto è stato quello di studiare gli effetti della NETosi sulla 
guarigione delle ulcere dei pazienti diabetici, avvalendoci anche dell’uso di un modello 
sperimentale animale. L’analisi proteomica iniziale ci ha permesso di identificare le 
proteine coinvolte in questo processo; inoltre, abbiamo osservato che nel sangue dei 
pazienti diabetici vi è una sovra-espressione di alcuni di questi componenti. I neutrofili 
isolati da questi pazienti mostrano: 
1- un incremento della NETosi spontanea;  
2- un’alterata NETosi indotta;  
3- un’aumentata attività dell’enzima PAD4.  
Per studiare meglio questo processo abbiamo messo a punto una tecnica di imaging 
intravitale nell’ulcera di modello murino, che parallelamente all’analisi citofluorimetrica 
degli istoni citrullinati, ha messo in risalto il coinvolgimento della NETosi nel processo di 
guarigione delle ulcere diabetiche. Inoltre l’inibizione di PAD4 nel topo, ha dato evidenze 
sperimentali di un miglioramento nella guarigione delle ulcere. 
In futuro questo protocollo sperimentale potrebbe essere utilizzato come strategia 
terapeutica di modulazione della NETosi per migliorare le DFU nei pazienti diabetici.  
Introduction 
Diabetes is one of the most common chronic diseases worldwide [1]. It is well known 
that diabetes mellitus (DM) affects blood cells. Altered susceptibility to infection of 
patients with diabetes has been ascribed to a depression in the function of 
polymorphonuclear (PMN) leukocytes. In diabetic patients with good glucose control, 
neutrophil function is slightly different than that of healthy ones. Diabetes causes 
significant changes in lymphocytes’ metabolism and functions [2]. Increased risk of the 
occurrence of cardiovascular events is observed with the intensity of the inflammation 
which is reflected, among others, in elevated number of peripheral blood leukocytes. 
Attention is drawn to the higher rate of complications in patients with increased 
baseline leukocytosis. The correlation between the increase in leukocyte count and all-
cause mortality is statistically significant. A higher risk of non-fatal myocardial infarction 
is also observed with the increase of leukocytosis. Neutrophils, which are the main pool 
of white blood cells, may play a role in these unfavorable phenomena [3]. 
Patients with diabetes, presenting with acute coronary syndrome, are at higher risk of 
cardiovascular complications and recurrent ischemic events in comparison to non-
diabetic counterparts. Various mechanisms, including endothelial dysfunction, platelet 
hyperactivity, and abnormalities in coagulation and fibrinolysis have been implicated for 
this increased atherothrombotic risk [2]. 
 
Diabetes and DFU 
415 million adults are estimated to currently have diabetes and there are 318 million 
adults with impaired glucose tolerance, which puts them at high risk of developing the 
disease in the future. By 2040 the number of people with diabetes is esteemed to rise to 
642 million, of which 71 million only in Europe [4]. 
Diabetes is the most common cause of non-traumatic limb amputation in western 
countries [5]. Foot ulceration is a leading cause of hospital admissions for people with 
diabetes in the developed world and is a major cause of morbidity associated with 
diabetes, often leading to a poor quality of life for patients. Diabetic foot ulcers (DFUs) 
are estimated to occur in 15% of all patients with diabetes and precede 84% of all 
diabetes-related lower-leg amputations [6]. Most commonly, patients have neuropathy, 
which could be causative to DFUs. When coupled with an impaired ability to fight 
infection, these patients become largely unable to mount the balanced inflammatory 
response that is required for wound healing. Thus, the DFUs could unleash an infection 
that can lead to sepsis and require limb amputation. 
Several factors contribute to wound healing deficiencies in individuals with diabetes 
such as an impaired growth factor production and macrophage function, an altered 
collagen accumulation, a less vascularized granulation tissue, a dampened keratinocyte 
and fibroblast migration and proliferation, reduced number of epidermal nerves and a 
dysregulated balance between the accumulation of ECM components and their 
remodeling by MMPs [6] (see Figure 1). 
 
Figure 1 Mechanisms of wound healing in healthy people versus people with diabetes. In healthy individuals 
(left), the acute wound healing process is guided and maintained through integration of multiple signals (in 
the form of cytokines and chemokines) released by keratinocytes, fibroblasts, endothelial cells, 
macrophages, and platelets. During wound-induced hypoxia, VEGF released by macrophages, fibroblasts, 
and epithelial cells induces the phosphorylation and activation of eNOS in the bone marrow, resulting in an 
increase in NO levels, which triggers the mobilization of bone marrow EPCs to the circulation. The chemokine 
SDF-1a promotes the homing of these EPCs to the site of injury, where they participate in neovasculogenesis. 
In a murine model of diabetes (right), eNOS phosphorylation in the bone marrow is impaired, which directly 
limits EPC mobilization from the bone marrow into the circulation. SDF-1a expression is decreased in 
epithelial cells and myofibroblasts in the diabetic wound, which prevents EPC homing to wounds and 
therefore limits wound healing. 
 
Wound repair 
Regeneration and tissue repair processes consist of a sequence of molecular and cellular 
events which occur after the onset of a tissue lesion in order to restore the damaged 
tissue. All the events involved in wound repair can be divided into the following stages: 
inflammatory reaction, cell proliferation and synthesis of the elements which make up 
the extracellular matrix, and the posterior period, called remodeling. These stages are 
not mutually excluding, but rather overlap over time (Figure 2) [7]. 
 
Figure 2 The 3 stages involved in tissue repaired. Image taken from [7]. 
The exudative, proliferative, and extracellular matrix remodeling phases are sequential 
events that occur through the integration of dynamic processes involving soluble 
mediators, blood cells, and parenchymal cells. Exudative phenomena that take place 
after injury contribute to the development of tissue edema. The proliferative stage seeks 
to reduce the area of tissue injury by contracting myofibroblasts and fibroplasia. At this 
stage, angiogenesis and re-epithelialization processes can still be observed. Endothelial 
cells are able to differentiate into mesenchymal components, and this difference 
appears to be finely orchestrated by a set of signaling proteins that have been studied in 
the literature. This pathway is known as Hedgehog [7]. 
In this thesis work, we focus the attention on the first phase in wound repairs, the 
inflammatory stage. In this phase, cell response is characterized by the influx of 
leukocytes in the wound area. Such a response is very quick and coincides with the key 
signs of inflammation, which are revealed by the edema and the erythema at the 
location of the lesion. Normally, cell response is established within the first 24 hours and 
can extend for up to two days. A quick activation of the immune cells in the tissue may 
also occur. Inflammation is a localized and protective tissue response that is unleashed 
by the lesion, causing tissue destruction [7]. Inflammatory cells play an important role in 
wound healing and contribute to the release of lysosomal enzymes and reactive oxygen 
species, as well as facilitate the clean-up of various cell debris [8]. 
Neutrophils are among the first leukocytes to reach the wound after damage. Their 
canonical role is to eradicate bacteria and pathogens from the wound bed to be to kill 
microbes. This is usually achieved in phagolysosomes, but often results in neutrophils 
blitzing their environment with free radicals and other humoral factors that could kill 
host cells as well as the target infectious agents (this is particularly apparent in chronic 
wound situations) [9]. Brinkmann et al [10] have shown that another tactic for killing by 
neutrophils involves trapping microbes in extruded NETs of histones and DNA, process 
called NETosis. 
 
Neutrophils and NETosis 
Neutrophils, the most abundant leukocyte in the human body, have long been viewed as 
short-lived effector cells of the innate immune system, possessing limited capacity for 
biosynthetic activity and with a primary role in resistance against extracellular 
pathogens and in acute inflammation. These cells are characterized by their ability to act 
as phagocytic cells, to release lytic enzymes from their granules and to produce reactive 
oxygen intermediates (ROI) with antimicrobial potential. This view was challenged a few 
decades ago, by suggesting that neutrophils could survive much longer than first 
suggested [11]. Recently, it has been convincingly demonstrated that human neutrophils 
are short-lived, with a half-life of less than 1 day [12]. Latest  evidence suggests that 
neutrophils can also produce anti-inflammatory molecules and factors that promote the 
resolution of inflammation [11]. The microbicide activity of neutrophils was known to be 
mediated by granule enzymes and oxidative burst, but it was recognized that activated 
neutrophils release granule proteins and chromatin that together form extracellular 
fibers that trap bacteria [10]. These so-called neutrophil extracellular traps (NETs) 
account for most of the ability of neutrophils to clear microorganisms. Release of 
nuclear material in NETs is followed by a type of cell death called NETosis. 
It is still debated whether NETs release represents an active and specific physiological 
host defense mechanism or is simply a consequence of cellular rupture due to toxins or 
trauma. In 1996, neutrophil “suicide”, distinct from either necrosis or apoptosis, was 
described following chemical stimulation with phorbol myristate acetate (PMA). Fuchs 
and colleagues [13] argued that PMA-induced DNA release could represent a novel host 
defense form of beneficial suicide, subsequently coined “NETosis.” 
Neutrophils-generated NETs are structures composed of granule and nuclear 
constituents (proteolytic enzymes, antimicrobial proteins and ROS) that disarm and kill 
bacteria extracellularly. Notably, NETs are released only by activated neutrophils. 
Although naïve cells are round-shaped with some membrane folds (Figure 3 A and C), 
neutrophils stimulated with interleukin-8 (IL-8), PMA, or lipopolysaccharide (LPS) 
become flat and form membrane protrusions (Figure 3 B). Activated neutrophils but not 
naïve cells made prominent extracellular structures (arrows, Figure 3, B and D). These 
fibers, or NETs, are very fragile, and specimens need to be washed and fixed carefully to 
preserve them. High-resolution scanning electron microscopy (SEM) showed that the 
NETs contain smooth stretches with a diameter of 15 to 17 nm and globular domains of 
around 25 nm (Figure 3 E, arrowheads) that aggregate into larger threads with 
diameters of up to 50 nm. Analysis of cross sections of the NETs by transmission electron 
microscopy (TEM) revealed that they are not surrounded by membranes (Figure 3 F). 
 Figure 3 Electron microscopical analysis of resting and activated neutrophils. (A) Resting neutrophils are 
round and devoid of fibers. (B) Upon stimulation with PMA for 30 min, the cells flatten, make many 
membrane protrusions, and form fibers (NETs), arrows in (B) and (D). (C) TEM analysis of naïve neutrophils in 
suspension. (D) Ultrathin section of neutrophils stimulated in suspension with IL-8 for 45 min. Bars in (A) to 
(D) indicate 10 µm. The multilobular nuclei and different granules are clearly visible in both figures. The 
activated cells in (D) have many pseudopods and show NETs (arrow). (E) High-resolution SEM analysis of 
NETs that consist of smooth fibers (diameters of 15 to 17 nm, arrowheads) and globular domains (diameter 
around 25 nm, arrow). Globular complexes can be aggregated to thick bundles or fibers. (F) Ultrathin 
sections of NETs show that they are not membrane-bound. Neutrophils were stimulated as in (D). Bars in (E) 
and (F), 500 µm. Image taken from [10] 
  
Molecular mechanism of NETosis 
The events taking place during NETosis appear to follow a coordinated multi-step 
process that identifies a new type of programmed cell death: histone citrullination, 
chromatin decondensation, migration of elastase and other granule enzymes into the 
nucleus, disintegration of the nuclear membranes and release of DNA, histones and 
granule proteins into the extracellular space [14]. Owing to its negative charges, DNA 
forms the sticky backbone of NETs, onto which histones and enzymes attach (Figure 4). 
These filaments organize in networks that physically entrap bacteria, but also allow the 
local concentration of bactericidal components, that could not be possible if they were 
freely released in the extracellular fluid, whence they would be rapidly cleared [14]. DNA 
fibers are decorated with several proteins like neutrophil elastase (NE), myeloperoxidase 
(MPO), cathepsin G, proteinase 3 (PR3), high mobility group protein B1 (HMGB1), and 
LL37, thus displaying proinflammatory characteristics [15]. 
 
Figure 4 Outline of NET formation. (1) Initiation of NETosis generally occurs through engagement of cell 
surface receptors. While invasion itself is not required, it is possible that adhesion enables high local 
concentrations of parasite ligands that trigger the NET cascade. (2) Evidence indicates involvement of the 
Raf–MEK–ERK pathway during NET formation elicited by several stimuli. In most cases, NADPH oxidase is 
also involved. (3) Signaling to the nucleus results in chromatin modification. Histone citrullination mediated 
by peptidyl arginine deiminase (PAD)appears to be a prerequisite for NET release. (4) Concurrent with 
chromatin decondensation, the nuclear membrane disintegrates. (5) This results in mixing of cytoplasmic, 
granule (yellow and red circles) and nuclear contents. (6) Finally, DNA with associated histones and granule 
molecules are released into the extracellular environment entrapping microbes in the vicinity. Image taken 
from [16]  
Citrullination is the conversion of positively charged arginine side chains into polar but 
uncharged citrulline side chains, by deimination. Of the five-known human 
peptidylarginine deiminases (PADs) known to catalyze such conversions, PAD4 is the 
most extensively studied isoform. It is expressed by various leukocytes, including 
neutrophils and immuno-modulatory functions have been ascribed to PAD4 activity. Like 
other PAD isotypes, PAD4 is a Ca2+ dependent enzyme, but only PAD4 possesses a 
classical nuclear localization signal (NLS). Importantly, the citrullination of nuclear 
histone H3 has been reported to counteract transcription by preventing the methylation 
of arginine. In neutrophils, inhibition of PAD4 prevents citrullination of histone H3 and 
significantly reduces NETs release induced by a Ca2+-ionophore or Shigella flexneri 
bacteria in differentiated HL60 cells. These data suggest that nuclear histones have a 
regulatory role during NETosis in addition to their direct antimicrobial role [17]. 
In 2007, it was reported that, going along with chromatin decondensation, neutrophils 
undergo an NADPH oxidase-dependent death process that includes nuclear envelope 
disintegration and the mixing of nucleic acids and granule proteins within a large 
intracellular vacuole [13]. This is followed by plasma membrane rupture and the release 
of chromatin, decorated with granular proteins, into the extracellular space. In vitro 
NETosis is completed in 1 to 4 h after the triggers were added to neutrophils [15].  
 Figure 5 Triggers and steps of NETosis. This Figure was produced using Servier Medical Art: www.servier.com 
It is reported that treatment with pro-inflammatory stimuli, such as LPS, IL-8, fMLP (N-
Formylmethionyl-leucyl-phenylalanine) or Shigella flexneri induces a marked increase in 
the citrullination of histone H3. 
The cascade of events in the intracellular signaling pathway that follows is poorly 
known, but it culminates in the activation of NADPH oxidase (NOX), as the 
compartmentalized NOX-dependent oxidative burst is one main feature of NETosis [17]. 
In vitro, NETosis is typically stimulated by the protein kinase C (PKC) PMA. In turn, PKC is 
responsible for membrane translocation and assembly of the NOX complex to allow 
neutrophil respiratory burst [18]. The importance of NOX in NETosis is highlighted by the 
finding that patients with chronic granulomatous disease, who carry mutations in NOX 
components, show a severe deficiency in NETs release, which can contribute to their 
susceptibility to infections. Other features of this PMA-inducible NOX-dependent 
NETosis are activation of ERK1/2, p38 MAP kinase, Akt, and the autophagic machinery. 
Activation of Akt, in particular, is believed to shift balance between apoptosis and 
NETosis toward the latter in neutrophils. In addition, a NOX-independent NETosis 
pathway has been recently described, which can be induced by calcium ionophores (e.g. 
ionomycin and a23187) and is mediated by small conductance potassium (SK3) channels 
and mitochondrial ROS [19]. 
Bacterial damage-associated molecular pattern (DAMPs), such as LPS, are known 
triggers of autophagy in many cell lines, including neutrophils. However, purified LPS 
does not activate NADPH oxidase directly, but only sensitizes for a more powerful 
NADPH oxidase-derived oxidative burst induced by a subsequent trigger of NADPH 
oxidase. Formylated oligo peptides, like fMLP, are potent triggers of NADPH oxidase. 
Consequently, fMLP activates NADPH oxidase as well as Histone H3 citrullination. 
However, fMLP does not induce NETosis. The fMLP induces signaling through Akt/PI3K 
as well. This cascade PI3K/Akt/mTOR may inhibit autophagy and thereby prevent 
NETosis. Both reactive oxygen species (ROS) production and H3 citrullination are 
insufficient to mediate the collapse of the nuclear membrane. Accordingly, hydrogen-
peroxide (H2O2) only accelerates neutrophil apoptosis. Induction of autophagy without 
NADPH oxidase activity also results in enhanced apoptosis, with no signs of NETosis. 
However, ROS, which are sufficient to induce consequent H3 citrullination, in 
combination with induced autophagy leads to chromatin decondensation and collapse 
of the nuclear membrane and prevents the activity of executioner caspases (Figure 5). 
 
Ca2+ flux is necessary for efficient NET formation, and its role does not seem to be 
restricted to the generation of ROS, but also promotes histone citrullination by PAD4; 
PAD4 is a Ca2+-dependent enzyme, that is key in mediating NETosis [20]. The activation 
of protein kinase C (PKC) by PMA has also been shown to be important, and appears to 
depend on phosphorylation of p38 MAPK and ERK, by a pathway that may suppress 
apoptosis to permit NETosis [21]. 
Downstream Ca2+ signaling induced by IL-8 in neutrophils occurs in two phases: a rapid 
initial release from intracellular stores, mainly from the endoplasmic reticulum via the 
activation of phospholipase Cβ (PLC) and the subsequent action of IP3, followed by a 
prolonged influx mediated by the activation of Ca2+ release activated Ca2+ (CRAC) 
channels. A graphical summary of the potential signal-transducing cascade is provided in 
Figure 6. 
 
Figure 6 Schematic representation of the Ca2+-dependent signal transduction pathway of NETosis. Image 
taken from [21]. 
 
NETosis: a distinct cell death program 
NETosis is distinct from necrosis, apoptosis, necroptosis and autophagy: though some 
characteristics of NETosis can be found in other types of cell death, such as membrane 
degradation and Ca2+ overload, other features are quite specific.  
In contrast to apoptotic cells, NETotic cells do not display eat-me signals such as 
phosphatidyl serine (PS) before plasma membrane disruption, preventing their 
clearance by phagocytes (Figure 7). Live cell imaging of healthy neutrophils stimulated 
with 100 nM PMA reveals a cell death program characterized by immediate cell 
flattening and increased adherence, followed by loss of mitochondrial membrane 
potential and induction of vacuolization [22]. Differently to apoptosis or programmed 
necrosis (necroptosis), both the nuclear and granular membranes disintegrate during 
NETosis, but plasma integrity is maintained. This allows the antimicrobial granular cargo 
to mix with nuclear chromatin. No morphologic signs of apoptosis are observed, such as 
membrane blebbing, nuclear chromatin condensation, PS exposure before plasma 
membrane rupture and internucleosomal DNA cleavage [17]. 
 
Figure 7 Live cell imaging of subcellular events during ex vivo neutrophil apoptosis and NETosis. (a and c) 
Cells were incubated with Alexa488-AnnexinV (green) and the cell-impermeable DNA dye propidium iodide 
(red), (b and d) or with the cell impermeable DNA dye Hoechst (blue), the mitochondrial membrane potential 
marker TMRM (red) and the cell impermeable DNA dye, propidium iodide (green). Constitutive neutrophil 
apoptosis is characterized by membrane blebbing, PS exposure (green) and condensation of nuclear 
chromatin (blue); cells finally undergo secondary necrosis. During induced NETosis, cells display massive 
vacuolization and decondensation of nuclear chromatin (blue), and PS is not exposed (green) before NET 
formation (green). Scale bars indicate 10 mm. Image taken from [17] 
PMA induces typical features of NETosis, which differs both biochemically and 
morphologically from apoptosis and necrosis. Remijsen and colleagues [22] confirmed 
by live cell imaging of PMA-stimulated healthy neutrophils, that NETosis is characterized 
by: immediate cell flattening and increased adherence, loss of mitochondrial membrane 
potential and induction of massive vacuolization (Figure 8 A). Vacuolization is observed 
for up to 90-130 min after PMA stimulation, until the nuclear envelope disintegrates and 
nuclear chromatin decondenses, which allows it to mix with the cytoplasmic content. 
During all that time, plasma membrane integrity is preserved. After 140 min, the plasma 
membrane permeabilizes and decondensed chromatin is released. Figure 8 B shows the 
mean percentage of cells undergoing to these different subcellular events from a kinetic 
analysis of 150 cells from four independent experiments. Mitochondrial depolarization is 
not a crucial mediator of DNA decondensation. In this regard, it is noteworthy that 
neutrophils depend on glycolysis instead of oxidative phosphorylation to meet their 
energy demands. 
 
Figure 8 PMA-induced NETosis is characterized, chronologically, by cell flattening and adherence, a drop in 
mitochondrial membrane potential, vacuolization and intracellular chromatin decondensation. (A) Isolated 
neutrophils were monitored by live cell imaging. (B) Kinetic analysis of 150 neutrophils. 
NETosis differs also from another regulated cell death mechanism, which will be 
described followed and is called necroptosis. This process is well defined as a viral 
defense mechanism, allowing the cell to undergo “cellular suicide” in a caspase-
independent fashion in the presence of viral caspase inhibitors [23]. Necroptosis is 
similar to apoptosis, however there are some differences, which are schematically 
represented in Figure 9. 
  
 Figure 9 TNFR1‑elicited signaling pathways. (A) On TNF binding, TNFR1 undergoes a conformational change, 
allowing for the intracellular assembly of the so-called TNFR complex I, which includes TNF receptor-
associated death domain (TRADD), receptor-interacting protein 1 (RIP1; also known as RIPK1), cellular 
inhibitor of apoptosis proteins (cIAPs), TNF receptor-associated factor 2 (TRAF2) and TRAF5. On cIAP-
mediated Lys63‑ubiquitylation, RIP1 can serve as a scaffold for the recruitment of transforming growth 
factor‑β activated kinase 1 (TAK1), TAK1‑binding protein 2 (TAB2) and TAB3, which initiate the canonical 
nuclear factor-κB (NF-κB) activation pathway (BOX 2). Riboflavin kinase (RFK) physically bridges the TNFR1 
death domain to p22phox (also known as CYBA), the common subunit of multiple NADPH oxidases, including 
NADPH oxidase 1 (NOX1), which also contributes to TNFα-induced necroptosis by generating reactive oxygen 
species (ROS). Conversely, on deubiquitylation by cylindromatosis (CYLD; and perhaps also by A20 (also 
known as TNFAIP3), cezanne (also known as OTUD7B) or ubiquitin-specific peptidase 21 (USP21)), RIP1 
exerts lethal functions, which can be executed by two distinct types of cell death. (B) The internalization of 
TNFR1 is accompanied by a change in its binding partners that leads to the cytosolic assembly of TNFR 
complex II, which often (but not invariably) contains TRADD, FAS-associated protein with a death domain 
(FADD), caspase 8, RIP1 and RIP3 (also known as RIPK3). Normally, caspase 8 triggers apoptosis by 
activating the classical caspase cascade. It also cleaves, and hence inactivates, RIP1 and RIP3. (C) If caspase 
8 is blocked by pharmacological or genetic interventions, RIP1 and RIP3 become phosphorylated and engage 
the effector mechanisms of necroptosis. FAD, flavin adenine nucleotide; FMN; flavin mononucleotide. Image 
taken from [24]. 
In contrast to constitutive or anti-Fas-induced neutrophil apoptosis, PMA-induced 
NETosis was insensitive to the pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-
Asp(Ome)-fluoromethylketone (zVAD-fmk). Caspase activity is only detected during 
spontaneous neutrophil apoptosis, but not during PMA induced NETosis. Moreover, the 
kinetics of PMA-induced NETosis are not affected by treatment with zVAD-fmk (Figure 
10 A). These findings could exclude the involvement of caspases in NETosis. 
NETosis process is different also to necrosis. Several necrostatins have been identified 
by virtue of their ability to suppress necrosis induced by TNF. The inhibition of 
programmed necrosis by pretreatment with necrostatin-1 (Nec-1), an inhibitor of RIP1 
kinase activity, also does not affect the kinetics of PMA-induced NETosis [22] (see Figure 
10 C). 
 
Figure 10 PMA-induced NETosis differs from neutrophil apoptosis and necroptosis. (A) In the presence of 50 
nM Sytox Green, 2 x105 neutrophils were incubated with or without 10 μM zVAD-fmk for 30 min. They were 
left unstimulated or were stimulated with 100 nM PMA or 250 ng/ml anti-Fas antibody for the indicated 
times. Cell death was detected by measuring the fluorescence of the cell impermeable DNA dye Sytox Green. 
Data are expressed as mean Sytox Green fluorescence ± SD (n= 3), as percentage of maximal Sytox Green 
fluorescence. zVAD-fmk significantly inhibited anti-Fas stimulated DNA release, whereas zVAD-fmk did not 
significantly inhibit PMA-induced DNA release. (B) Protease activity against the caspase substrate DEVD-amc 
was determined. Data are expressed as the mean ΔF/min ± SD (n=3). *, p< 0.05 and **, p< 0.001, as 
compared to PMA-stimulated neutrophils. (C) Neutrophils (2 x105) were incubated with or without 5 or 10 
μM Nec-1 for 30 min, and either left unstimulated or were stimulated with 100 nM PMA for the indicated 
durations, in the presence of the cell impermeable DNA dye Sytox Green (50 nM). Data are expressed as 
percentage of maximal Sytox Green fluorescence ± SD (n=4) as a function of time. *, p< 0.01, as compared to 
PMA stimulated normal neutrophils. Image taken from Supplementary [22]. 
Suicidal NETosis vs vital NETosis 
In 1996, neutrophil suicide, distinct from either necrosis or apoptosis, was described 
following chemical stimulation with PMA [25]. The potential importance of this 
observation went unrecognized until the Zychlinsky laboratory reported that PMA-
induced suicide resulted in the release of a novel host defense structure, named NETs 
[10]. 
This classical “suicidal” NETosis occurs in vitro following stimulation by PMA through 
activation of protein kinase C and the RAF–mitogen-activated protein kinase (MEK)–
extracellular signal-regulated kinase (ERK) pathway. NADPH assists in the translocation 
of neutrophil elastase from cytosolic granules into the nucleus where it aids in 
chromatin breakdown via histone cleavage. MPO is required for chromatin and nuclear 
envelope breakdown and granular mixing within the NET vacuole. Following 120 min of 
intracellular NET formation, the neutrophil outer membrane ruptures, and the mature 
NET is extruded (Figure 11 A-C). On the other hand, Yipp et al [26] have provided 
evidence of a “vital” NETosis pathway distinct from suicidal NETosis, where neutrophils 
after the release of NET are alive. 
Vital NETosis has been reported following both direct microbial exposure and LPS. Live S 
aureus induce rapid NET release (<30 minutes) in human and mouse neutrophils in vitro 
and in vivo. For gram-negative bacteria, NETs are induced via Toll-like receptor (TLR) 4 
activation of platelets followed by direct neutrophil-platelet interaction via CD11a, 
whereas both complement receptor 3 and TLR2 are required for vital NETosis following 
gram-positive infection (Figure 11 D-F) [26]. 
 Figure 11 The comparison of two different mechanisms of conventional suicidal NETosis vs vital NETosis. 
Image taken from [26] 
 
NETosis in diabetes 
Constitutively active innate immune responses are associated with pathophysiological 
conditions of several diseases such as diabetes and obesity, autoimmune, 
neurodegenerative disorders and thrombosis related diseases. As an essential 
component of innate immune system, neutrophils play an important role by inducing 
hyper-responsive pro-inflammatory milieu during the pathogenesis of such diseases 
[27]. 
Whereas type 1 diabetes is characterized by autoimmune destruction of pancreatic 
islets, type 2 diabetes (T2D) has been described as an autoinflammatory disorder, 
characterized first by insulin resistance in peripheral tissues followed by beta cell failure, 
including decreased islet size and insulin production.  
Chronic low grade tissue inflammation is an important cause of systemic insulin 
resistance, and is a key component of the decreased insulin sensitivity which exists in 
obesity and T2D. Immune cells such as macrophages, T–cells, B–cells, mast cells and 
eosinophils have all been implicated as playing a role in this process. Neutrophils are the 
first immune cells to respond to inflammation, and can promote a more chronic 
inflammatory state by helping to recruit macrophages and interacting with antigen 
presenting cells [11]. 
A dysregulation in NETosis can represent a hitherto neglected link among 
hyperglycemia, oxidative stress, inflammation and diabetic complications, for 3 reasons: 
(1) diabetes affects neutrophil count and activity, (2) hyperglycemia-driven oxidative 
stress paves the way to diabetic complications and (3) neutrophils generate oxidative 
stress in diabetes. Under diabetic conditions, neutrophils produce more superoxide and 
cytokines than in normoglycemic conditions. Tumor necrosis factor-α (TNF-α), which 
primes neutrophils for NETs release, is increased in diabetic individuals [28]. The diabetic 
microenvironment may thus facilitate NETosis [20]. Indeed, our laboratory [29] has 
recently reported that high glucose in vitro and hyperglycemia in patients with diabetes 
increased NETosis and its surrogate markers, respectively. 
Increased NETosis in diabetes suggests that NETs may play a role in diabetic 
complications, and that inhibiting NETosis or cleavage of NETs may lessen them [20]. 
Local infection, which is common in DFU, triggers neutrophil activation and the release 
of NETs composed of granular proteins/enzymes and nuclear material, such as DNA and 
histones complexed in chromatin [17]; however, excess or deregulated NETosis can 
cause tissue damage. Wong et al. [20] found that PAD4, the key enzyme triggering NETs 
release, is overexpressed in diabetes, and NETosis induction can be demonstrated in 
murine models of DFU. Remarkably, the inhibition of NETosis by PAD4 knock-out or 
disruption of NETs with DNase-1 accelerated wound healing.  
  
Aim 
The aim of this work is to study the role of NETosis in delayed diabetic wound healing in 
humans. To accomplish that we coupled data generated from proteomic analysis of DFU 
with in vivo model of diabetic ulcers analyzed with intravital microscopy. Furthermore, 
we deployed a custom-build two-photon microscopy to study and dissect the single step 
of NETosis in vitro. A better comprehension of cellular and molecular mechanisms that 
delay tissue healing in diabetes could help for new therapeutic strategies beyond 
glucose control, revascularization, and traditional wound care.  
Material and methods 
Multiphoton microscopy 
The development of multi-photon intravital microscopy has been a breakthrough 
technique for deep-tissue imaging of dynamic cell behavior inside live organisms [30]. 
The Multi-Photon Microscopy (MPM) is a form of laser-scanning microscopy, which 
represents the best non-invasive imaging technique. MPM shows several advantages 
compare to convention confocal imaging: high resolution, reduced signal-loss due to 
light scattering from the regions above the focal plane, and the possibility to reach 1 µm 
depth [31]. 
The acquisitions of all the experimental data were performed with a costume-made 
two-photon microscope (Bergamo II, Thorlabs), which was designed in collaboration 
with Prof. Fabio Mammano (CNR, Rome) e Prof. Filippo Romanato (University of Padua). 
It is equipped with 8 kHz resonant scanner, extended-field-of-view collection optics, 4 
independent detection channels in the backward direction and laser-scanned Dodt 
contrast in the forward direction. The microscope was coupled to two synchronized 
pulsed laser beams generated by a Ti:Sapphire pump laser (Chameleon Ultra 2, 
Coherent) and an optical parametric oscillator (Camelion Compact OPO).  
Two-photon microscopy at 800 nm excitation was used to visualize simultaneously 4 
channels: green channel, blue channel, red channel and gray channel (transmitted light, 
for in vitro cell structure, or SHIM in vivo). SHIM or Second-Harmonic Imaging 
Microscopy is an imaging technique, which is based on nonlinear optical effect known as 
second-harmonic generation (SHG) and it allows us to visualize cell and tissue structure 
and function, like collagen or microtubule. Experiments were performed with a 60x 
objective (Olympus LUMFLN60XW, N.A. 1.1, 1.5 WD) or a 25x objective optimized for 
multiphoton imaging (Olympus XLPLN25XWMP2, N.A. 1.05, W.D. 2 mm). 
 
 Figure 12 On the left, our two-photon microscope; in the center, an example of NETosis imaging represents 
in all channels, taken simultaneously; on the right, a merge of all channels. 
 
Isolation of human neutrophils, stimulation of NETosis and in vitro 
imaging 
Neutrophils were isolated from EDTA-treated peripheral blood of healthy subjects using 
an immune-magnetic isolation kit, which yielded a highly pure neutrophil population 
(MACSxpress Human Neutrophil Isolation Kit, Miltenyi Biotec). 
We stained neutrophils using different dyes, the characteristics of which are 
summarized in Table1.
Table 1 
Channel Dye Concentration Incubation 
timing at 37°C 
Target 
Blue channel 
(460/50nm) 
Hoechst 33342 
(cell-permeable) 
1 µg/mL 5 min Nuclear 
dsDNA 
Green 
channel 
(525/40nm) 
Sytox green 
(cell-
impermeable) 
100 nmol/L Immediately in 
the medium 
Extracellular 
dsDNA in NETs 
Fluo-4 10 µM 20 min 
+ 20 min 
washing 
Intracellular 
calcium 
ROS dye 50 µM 30 min Intracellular 
ROS 
PKH green 4 µM 5 min Cellular 
membrane  
Alexa488-
polyclona-rabbit 
anti-human 
elastase 
1:200 Stock 1h Elastase 
Red channel 
(625/90) 
Tetramethylrho
damine (TMRM) 
50 nmol/L 5 min Energized 
mitochondria 
AnnexinV 1:1000 Stock  1 h Phosphatidyl 
serine 
Cy3-coniugated 
Antihuman PL2-
3 monoclonal 
antibody 
1:200 Stock Immediately in 
the medium 
Subnucleosom
al complex of 
Histone 2A, 2B 
and chromatin 
 
To stimulate NOX-dependent NETosis, neutrophils were incubated with phorbol 12-
myristate-13-acetate (PMA) [100 nmol/L] at 37°C and 5% CO2 for 2 h. For stimulation of 
NOX-independent NETosis, neutrophils were incubated with calcium ionophores 
(a23187 at 25 µM concentration, and ionomycin at 5 µM concentration). 
The experiments were performed with an Olympus 60x objective. 
Animals 
All procedures were approved by the local ethics committee and from the Italian 
Ministry of Health. Experiments were conducted according to the National Institutes of 
Health Principles of Laboratory Animal Care. We used 30 wild-type C57Bl/6J mice 
(Jackson Laboratory), fed a standard diet containing 10% of energy from fat. 
Diabetes was induced with a single i.p. injection of streptozotocin (150 mg/kg, Sigma 
Aldrich) in citrate buffer pH 4.5. Glycaemia was measured with a commercially available 
glucometer (Abbott) and animals with blood glucose ≥300 mg/dl were housed for 4 
weeks before performing the experiments. 
To induce hind limb wounding, 10 animals were sedated with inhaled isoflurane 
(Abbott) and the lateral portion of the tight was shaved with Veet® cream. After skin 
disinfection, a 4 mm-round excisional full-thickness wound was performed with a skin 
biopsy punch (Kai Medical, Japan). Digital photographs of the wounds were taken at pre-
specified time points with a reference ruler to estimate wound area, that was calculated 
with ImageJ software (NIH). To ensure PAD4 inhibition, Cl-amidine (Merck Millipore) was 
injected daily subcutaneously at 10 mg/kg (in DMSO) for 1 week before performing 
excisional wounds and continued throughout healing. Control group received daily 
injection of the vehicle (DMSO). 
 
Intravital imaging 
10 mice were sedated with zolazepam/thylamine and xylazine, placed on a custom-
made holder, and positioned under an Olympus 25x objective. Wounds were evaluated 
at day 3. Thirty minutes before imaging, mice were intravenous (i.v.) injected with 5 µL 
Sytox green, 3 µL phycoerythrin-conjugated anti-mouse Gr-1, and 50 µL Hoechst 33342. 
In separate experiments, the vasculature of mice was stained by injecting i.v. 50 µL of a 
10 mg/dL solution of high–molecular weight (150 kDa) fluorescein isothiocyanate (FITC)–
conjugated Dextran. 
 Figure 13 Setting to allows us the visualization of ulcer in mice. 
 
Wound healing in mice 
To ensure PAD4 inhibition, Cl-amidine (Merck Millipore) was injected daily 
subcutaneously at 10 mg/kg (in DMSO) for 1 week before performing excisional wounds 
and continued throughout healing. Control group received daily injection of the vehicle 
(DMSO). 
Animals were sedated with inhaled isoflurane (Abbott) and the lateral portion of the 
tight was shaved with Veet® cream. After skin disinfection, a 4 mm-round excisional full-
thickness wound was performed with a skin biopsy punch (Kai Medical, Japan). Digital 
photographs of the wounds were taken at pre-specified time points with a reference 
ruler to estimate wound area, that was calculated with ImageJ software (NIH). 
 
Data and Statistical Analysis 
We used ImageJ/Fiji software (1.48r, NIH, USA) to process raw data files. We registered 
in different two ways: 1) z-stack recording (or focal plane merging and z-stacking or 
focus blending), which is a digital image processing technique which combines multiple 
images taken at different focus distances to give a resulting image with a greater depth 
of field than any of the individual source images; 2) streaming recording, which 
simultaneously take 4 channels during pre-fixed period. 
Proteomic Analysis 
Our laboratory has previously developed  and  validated  a  proteomic  platform  for  
identification  of  biomarkers  and  new  molecular  mechanisms  of  diabetic  wound  
healing [32].  This was based on proteomic characterization of  tissue  lysates  obtained  
from  wound  biopsies  in  patients, whose wound outcome could be defined as rapidly 
healing (RH, n=17) or non-healing (NH, n=11). Briefly, proteomic analysis was performed 
with iTRAQ labelling and mass  spectrometry  on  Matrix-Assisted Laser 
Desorption/Ionization Time-of-Flight (MALDI/TOF)  and  Orbitrap.  After bioinformatic 
analysis  of  peptides  and  sequence  coverage,  data  were  filtered  retaining  only  
proteins  identified by at least two unique peptides and with a false discovery rate <5%. 
Abundance of individual proteins  was  expressed  as  the  NH/RH  ratio,  with  
confidence  interval  derived  from  technical  triplicate over  the  background  generated  
by  swapping  iTRAQ  labels.  We herein analyzed data to evaluate  whether  proteins  
associated  with  NETs showed  differential  abundance  in  NH  versus  RH wounds.  To  
this  end,  we  built  a  custom  pathway  made  up  of  proteins  that  have  been  
associated  with  NETs. A PubMed search was run on Sept 2014 with search string 
(“NETs” or “neutrophil extracellular traps” or “NETosis”): two reviews of the literature, 
published in 2013 and 2014 provided the best and  updated  overview  of  NET-
associated  proteins.  This  list  was  matched  with  the  list  of  proteins identified  in  
diabetic  wounds  as  described  above.  Proteins  were  divided  into  groups  according  
to  the belonging   cellular   compartment   (nucleus,   granules,   cytoplasm,   
cytoskeleton,   plasmamembrane). Individual  protein  relative  expression  was  
retrieved,  and  the  average  relative  expression  of  each compartment was calculated. 
To  validate  the  measure  of NET-associated  proteins  in  individual  wound  lysates,  we  
used  samples collected from patients of a “validation cohort”, who were divided 
according to the wound outcome at follow-up  in  those  whose  ulcer  had  worsened  
and  in  those  whose  ulcer  was  stable  or  healed.  We measured tissue elastase 
content using the Polymorphonuclear Elastase Human ELISA Kit (Abcam). 
 
Results 
Proteomic analysis of NETosis biomarkers 
Our group previously demonstrated that high glucose and hyperglycemia increase 
release of NETs and circulating markers of NETosis, respectively. These findings provide 
a link among neutrophils, inflammation and tissue damage in diabetes [29]. 
Screening the literature, we identified 25 proteins, belonging to 5 subcellular 
compartments (nucleus, granules, cytoplasm/cytoskeleton, enzymes, and plasma 
membrane), and we used them to create a custom NETosis pathway (see Figure 14 A 
and B). In our lab, we developed a proteomic-based technique for the identification of 
new candidate biomarkers and therapeutic targets in diabetic wound healing (see also 
the material and methods section) [32]. We therefore exploited the potential of this 
approach to assess the involvement of these proteins in the NETosis process. This 
strategy is based on a proteomic analysis of wound biopsies obtained from patients with 
DFUs, who were unequivocally categorized as rapidly healing (RH) or non-healing (NH). 
Several proteins were identified as differentially expressed in RH versus NH diabetic 
wounds, from a biopsy of the wound margin using tissue digestion, protein extraction, 
and proteomic analysis. The expression of granular and nuclear NET components was 
2.6- and 2.2-fold higher in NH versus RH wounds, respectively (P < 10-6 and P = 0.002, 
respectively). Nongranular enzymes were mildly (1.3-fold) but significantly (P < 10-4) 
enriched in NH versus RH wounds, whereas proteins of the cytoplasm, cytoskeleton, and 
plasma membrane were not significantly different between the two groups (Figure 14 B 
and C). The custom NETosis pathway was enriched in NH versus RH wounds, according 
to Gene Set Enrichment Analysis (GSEA) heat map (Figure 14 D).  
 Figure 14 Proteomic analysis of diabetic wound lysates. (A) Proteins belonging to the custom NETosis 
pathway are shown with their fold enrichment in NH vs. RH wounds. Error bars were derived from internal 
technical triplicates of the iTRAQ labels. The dashed line at onefold change aids visual identification of 
proteins with significant enrichment or depletion in NH vs. RH. Numbers on the left correspond to the cellular 
compartment illustrated in B. (B) Average fold enrichment for proteins in each subcellular compartment in 
NH vs. RH of proteins in the custom NETosis pathway (*P < 0.05). (C) Fold enrichment in NH vs. RH with 
dispersion shown by individual dots of NETosis pathway proteins grouped according to subcellular 
compartment (*P < 0.05 compared with 1.0). (D) Profile plot from the GSEA showing highly significant 
enrichment of most proteins of the custom NETosis pathway in the 4 replicates (Rep1–Rep4) compared with 
negative control subjects (Neg1-Neg2). False discovery rate–adjusted P value for this analysis, according to 
GSEA output, was <0.001, and normalized enrichment score was 2.06. (E) Wound elastase content (mg 
elastase/g tissue) in patients of the validation cohort showing stable/healed wounds vs. in those showing 
worsening wound evolution (*P < 0.05). (F) Wound elastase content in patients of the validation cohort with 
and without microbiologically proven infection (*P < 0.05). (G) Receiver operating characteristic curve 
showing the accuracy of wound elastase content in discriminating presence/absence of infection. 
These data indicate that typical granular and nuclear constituents of NETs are increased 
in the tissue lysates of NH diabetic wounds. 
We then quantified NET components (dsDNA, oligo- and mono- nucleosomes, and 
neutrophil elastase) in the tissue extracts of wound biopsies taken from an independent 
validation cohort of patients with DFUs. Patients were divided into two groups based on 
the wound outcome at a 6-month follow-up: worsening wounds (n = 12) and healed or 
stabilized wounds (n = 33). Neutrophil elastase, the prototypical NET marker, was 59% 
higher in worsening wounds compared with wounds that were stable or healed (P = 
0.03). These data suggest that local NETosis is associated with impaired wound healing 
(Figure 14 E). Infected wounds (20 of 45) had a 76% higher elastase content compared 
with noninfected wounds (P = 0.012; Figure 14 F). Based on the receiver operating 
characteristic curve, elastase quantification showed a high accuracy or identifying the 
presence of infection (area under the curve 0.815 [95% CI 0.686–0.944]; Figure 14 G). 
 
Circulating NETosis biomarkers in DFU 
Data shown in the previous paragraph suggest that NET-associated biomarkers are 
locally increased in NH wounds. Thus, we quantified NETosis biomarkers in the 
bloodstream of patients with DFUs, and compared them with those of diabetic patients 
without DFUs and healthy subjects as control. 
Circulating levels of oligo- and mono- nucleosomes, neutrophil elastase, NGAL, and 
proteinase-3 were significantly higher in patients with DFU compared with diabetic 
patients without DFUs and healthy volunteers (Figure 15 A, B, D and E);  instead 
circulating level of cell free dsDNA was not significantly increased in patients with DFUs, 
and the concentration of lactoferrin was not associated with diabetes or DFU (Figure 15 
C and F). More than 50% of patients had a microbial infection, mainly caused by Gram-
positive bacteria (mostly Staphylococcus aureus). S. aureus is known to produce and 
release DNases, which may explain why dsDNA was not significantly increased in the 
bloodstream of DFU patients. 
 
Figure 15 Circulating NETosis biomarkers in patients with DFU. (A–F) Serum neutrophil elastase (A), mono- 
and oligonucleosomes (B), cell-free dsDNA (C), NGAL (D), proteinase-3 (E), and lactoferrin (F) concentrations 
in participants, of which 26 healthy controls (CTRL), 26 diabetic patients without and 52 with DFU (post-
ANOVA *P < 0.05 vs. CTRL; †P < 0.05 vs. Diabetes; ‡P = 0.07 vs. CTRL).  
PAD4 is able to promote the citrullination of histones, and in a key enzyme in NETs 
production. Moreover, it was shown that PAD4 can be released in the extracellular 
space, to catalyze the citrullination of autoantigen proteins [33]. However, serum PAD4 
activity was almost undetectable in all of the patient groups (data not shown). These 
negative findings indicate that NETosis plays different roles in DFUs and autoimmune 
disorders. 
Patients were followed for an average of 4.5 months. Complete wound healing occurred 
in 53.8% of patients, partial healing in 17.3% and worsening in 5.7% (minor amputation 
occurred in 15.4% of patients, major amputation in 9.6% and revascularization in 
28.9%). Spontaneous healing without amputation or revascularization occurred in 36.5% 
of patients. 
Figure 16 shows the levels of serum neutrophil elastase in relation to wound outcomes: 
elastase concentration in patients with completely healed wounds was significantly 
lower in comparison with patients with NH DFU and it showed a tendency to decrease in 
patients with spontaneous healing (the latter was defined as complete healing without 
amputation or revascularization) (Figure 16 A). 
A logistic regression analysis showed that serum elastase was significantly inversely 
associated with complete healing (P = 0.046) after adjustment for infection and 
ischemia. According to the Kaplan-Meier curves, the probability of spontaneous healing 
over time was higher in patients with below-median elastase concentrations (P = 0.036) 
(Figure 16 B). 
 
Figure 16 Circulating elastase and wound outcomes. (A) Serum elastase concentrations are plotted in 
relation to wound outcomes (*P < 0.05). Minor and major amputations are herein pooled. (B) Kaplan-Meier 
curves showing the probability of spontaneous healing in patients categorized as having low (below-median) 
or high (above-median) serum elastase concentrations. 
These data confirmed that DFU patients had elevated circulating NET components. 
We next assessed whether the neutrophils isolated from DFU patients were primed 
toward NETosis. For this purpose, we purified neutrophils using non-activating 
immunomagnetic cell sorting and then evaluated spontaneous, NOX-dependent, and 
NOX-independent NETosis by incubating cells with PMA and the Ca2+ ionophore a23187, 
respectively  
We estimated NETs release, using quantitative assays for DNA-bound neutrophil 
elastase and myeloperoxidase (MPO), two NET proteins enriched in diabetic patients 
with NH wounds. Both elastase and MPO activity assays revealed a significant increase 
in the number of neutrophils primed for spontaneous NETosis in DFU patients (Figure 17 
D-E). The NOX-dependent release of DNA-bound MPO but not elastase was increased in 
patients with diabetes regardless of DFU (Figure 17 F-G). The NOX-independent release 
of elastase and MPO in NETs was lower in patients with diabetes compared with control 
subjects (Figure 17 H-I). 
We next calculated the fold induction of NOX-dependent and NOX-independent NETosis 
compared with the basal NETosis level for each group. There was a defect in NOX-
dependent (for MPO) and NOX-independent (for both elastase and MPO) NETosis in 
patients with DFUs (Figure 17 I-J). 
 
Figure 17 2—Circulating NETosis biomarkers in patients with DFU. Serum neutrophil elastase (A), mono- and 
oligonucleosomes (B), cell free dsDNA (C), NGAL (D), proteinase-3 (E), and lactoferrin (F) concentrations in 
participants without diabetes (CTRL), with diabetes (Diabetes), and with DFU (post-ANOVA *P < 0.05 vs. 
CTRL; †P < 0.05 vs. Diabetes; ‡P = 0.07 vs. CTRL). 
To summarize, these data suggest that in diabetic patients DFUs prime NETs release.  
Moreover, the induction of the NETosis process was compromised. 
 
In vitro imaging of NETosis 
Next step was to directly visualize single events that take place during NETs release. 
NETosis was pharmacologically induced in isolated human neutrophils (see below). In 
first place, we used immunofluorescence labeling of the nucleus, chromatin filaments, 
and neutrophil elastase. Figure 18 shows the presence of NETs filaments after a 2 h 
stimulation with PMA. 
 
Figure 18 Immunofluorescence of NETting neutrophils, which are stimulated with PMA for 2 h and stained 
with Hoechst 33342 (in blue) for nuclei, chromatin filaments (in red), and neutrophil elastase (in green). The 
scale bar is 50 µm. 
We observed that a fraction of neutrophils incubated with PMA underwent chromatin 
decondensation and histone citrullination, by a single-cell morphometric analysis. Figure 
19 shows condensed chromatin in blue (Hoechst 33342), and de-condensed chromatin 
in red, visualized by citrullinated histone H3. 
 
Figure 19 Above, neutrophils stimulated with PMA for 2 h and stained with Hoechst 33342 (blue) and 
citrullinated histone H3 (red). Below, morphometric analysis of fluorescence signals in neutrophils after PMA-
stimulation. The scale bar is 50 µm. 
Using transmission electron microscopy (TEM), we confirmed different morphology in 
NETting neutrophils, which had loss of nuclear lobulation and extrusion of decondensed 
chromatin compared with unstimulated neutrophils (see Figure 20). 
 
Figure 20 TEM of a non-NETting neutrophil (left) and a NETting neutrophil with loss of nuclear polylobulation 
(right). The scale bar is 5 µm. 
 
Subsequently, we performed a comparative study on neutrophils using high-resolution 
live cell imaging to analyze the potential interplay between intracellular calcium, 
mitochondrial membrane potential, intracellular chromatin decondensation and several 
morphological features.  
We took images up to 2 h using our custom two-photon microscope, and two examples 
are reported in Figure 21. According to literature [34], we noted that activated 
neutrophils underwent dramatic morphological changes: the nucleus lost its lobules, the 
chromatin decondensed, and the inner and outer nuclear membranes progressively 
detached from each other and, concomitantly, the granules disintegrated. 1 h after 
activation, the nuclear envelope disaggregated into vesicles and the nucleoplasm and 
cytoplasm formed a homogenous mass. Finally, the cells rounded up and seemed to 
contract until the cell membrane ruptured and the interior of the cell was ejected into 
the extracellular space, forming NETs. 
As shown in Figure 21 A, we recorded z-stacks of the same region, at 3 different time 
points following PMA stimulation:  
a) 1 h after stimulation some neutrophils have already undergone NETosis, while 
others still showed normally energized mitochondria and poly-lobulated nuclei;  
b) after 1 h and 20 min, more neutrophils have de-energized mitochondria, with a 
progressive chromatin decondensation and initial release of NETs 
(simultaneously stained with Hoechst 33342 and Sytox green); 
c) after 1 h and 40 min, extensive release of NETs from many neutrophils was 
evident. 
Figure 21 B contains representative images from a live video recording of the same 
process, that show a suggestive view of the events taking place during NETosis, from de-
energization of mitochondria to delobulation of nuclei and NETs release. The progressive 
nucleus enlargement and the following NET release, is clearly visible. See also Online 
Video ( https://www.youtube.com/watch?v=2jmwIocwWi0 ). 
 
 
Figure 21 Imaging of NETs formation in vitro. Nuclei are stained in blue with Hoechst 33342; mitochondria 
are stained in red with TMRM, which labels only energized organelles because its signal is proportional to 
Δψ; extracellular DNA is stained with Sytox green, present in the medium. Human neutrophils were immuno-
magnetically isolated, plated on plastic, stimulated with PMA, and imaged for up to 2h using a custom two-
photon microscopy. (A) In these snapshots, it is possible to recognize typical features of the NETosis process. 
(B) Live recording of the same process allows a suggestive view of the events taking place during NETosis. 
 
NETosis: a typical cell death mechanism 
In the previous paragraph, we have illustrated live cell imaging of healthy neutrophils 
stimulated with PMA, that revealed a cell death program characterized by immediate 
cell flattening, followed by loss of mitochondrial membrane potential and extrusion of 
nuclear dsDNA. 
We next wanted to establish if the death program induced by PMA was really NETosis, 
or if other cell death mechanisms are involved, and we did so by stimulating neutrophils 
in different ways. Neutrophils were either treated with H202 or subjected to UV rays. We 
noted that neutrophils undergoing apoptosis or necrosis showed phosphatidyl serine 
(PS) exposure, and indeed their outer cell membrane layer were AnnexinV-positive. In 
contrast, neutrophils releasing NETs showed membrane rupture and Sytox-positive 
labelling (Figure 22). 
 
Figure 22 Human neutrophils after 2h of PMA-stimulation: the majority underwent NETosis (Sytox+, green), 
the remaining were still intact, few went to apoptosis (AnnexinV+, red). 
According to Remijsen and colleagues’ observations [22], live imaging revealed that H202 
did not induce NETosis, as shown by the absence of cell flattening, adherence, massive 
vacuolization and intracellular chromatin decondensation in intact cells. At 100 µM 
concentration (well below 8 mM), H202 induced an apoptotic cell death morphology (see 
Figure 23) whereas, a higher H202 concentration induced a necrotic cell death (data not 
shown). These findings demonstrate that H202-mediated ROS generation is insufficient 
to induce intracellular chromatin decondensation and subsequent NET formation. 
 
Figure 23 Neutrophils, stimulated with 100 µM H202, undergone in apoptosis. 
 
We then wanted to study the involvement of caspases in the NETosis cascade. It was 
reported that NETosis appears as a caspase-independent cell death [17]. We verified this 
hypothesis by testing how the pan caspase inhibitor affected the kinetics of PMA-
induced NETosis. The treatment with 3-[2-(2-benzyloxycarbonylamino-3-methyl-
butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) did not affect NETs 
release kinetics (not shown). Our data are then compatible with the aforementioned 
hypothesis. 
As mentioned, classical necroptosis requires RIP1 (or RIPK1) for the activation of RIP3 
through the induction of RIP1/RIP3 necrosomes. However, there have been few RIP3 
inhibitors reported yet. B-RafV600E inhibitors are an important anticancer drug class for 
metastatic melanoma therapy. Recent study found that B-Raf inhibitors could inhibit 
RIP3 enzymatic activity in vitro [35]. We pre-treated neutrophils with Dabrafenib, which 
is an inhibitor of the associated enzyme B-Raf, and we noted that it did not affect the 
kinetics of PMA-induced NETosis (see Figure 24). Our results using Dabrafenib also 
demonstrate that caspase-independent cell death mediated by RIP1 kinase activity is not 
implicated in PMA-induced NETosis, which excludes its role in necroptosis. 
H2O2 100 μM for 1h
Hoechst 33342  Sytox green  Annexin V
 Figure 24 Different time points of neutrophils, stimulated with PMA and treated with Dabrafenib. 
All the above experiments confirmed that neither inhibition of caspases by zVAD-fmk 
nor inhibition of RIP1 kinases by Dabrafenib affected NETosis. Thus, NETosis should be 
considered a distinct cell death program 
 
Intracellular Ca2+ triggers NET release 
NETosis has been shown to relay on the generation of ROS by activation of the NAPDH 
oxidase and histone citrullination by PAD4 activity, both of which are Ca2+ dependent 
events [21].  In order to examine the role of Ca2+ in this process, we set up a new 
imaging protocol: we simultaneously monitored cell morphology, chromatin 
condensation, mitochondria and intracellular Ca2+ (for the latter, we used Fluo-4 that 
permits to achieve better signal to noise ratio; see Figure 25). 
 
Figure 25 Different channels of visualization of a single human neutrophil, which was pre-loaded with 
Hoechst 33342, Fluo-4 and TMRM, and anti-chromatin antibody in the medium. 
As already reported, NETosis was induced in neutrophils with PMA. We noted that, in 
parallel with peculiar characteristics of NETosis (changes in cell morphology and 
chromatin arrangement), intracellular Ca2+ had fluctuations. As shown in Figure 26, in 
the phase preceding the release of NETs, Ca2+ signal decreased and we saw a peak in 
fluorescence intensity, during nuclear DNA decondensation. 
See also Online Video ( https://youtu.be/8VeEP-GyYYM ) 
 Figure 26 Snapshots of PMA stimulated neutrophil show the simultaneous trend of cell morphology, nuclear 
DNA, Ca2+, decondensed chromatin and mitochondria potential. 
 
 
Figure 27 displays the plot of the fluorescence intensity variation over time, of all the 
channels reported in previous experiment. 20150304 B masked
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Figure 27 Graph of simultaneous fluorescence signals in stimulated neutrophil: condensed chromatin (blue), 
energized mitochondria (red), decondensed chromatin (yellow) and intracellular calcium (green). 
We, moreover, induced ionomycin stimulus in PMA-treated neutrophils (data not 
shown). 
Thus, our data demonstrate that the induction of NETosis requires mobilization of 
intracellular calcium pools. 
 
In vivo imaging and FACS analysis in the wound bed 
In the previous paragraphs, I showed data regarding the in vitro characterization of the 
NETosis process. We then investigated the role of NETosis in wound healing. As already 
mentioned, wound healing involves inflammation process and neutrophil recruitment 
from the nearby tissue. In order to detect in vivo neutrophil activation and NETs release, 
we developed a technique of intravital imaging in an ulcer mouse model. 
First, we tried to visualize neutrophils in the intact hind limb skin of mice. Neutrophils 
were detected only in capillaries (Figure 28). 
 Figure 28 Intravital microscopy imaging of neutrophils and the vasculature in the intact skin. Neutrophils are 
marked by PE-antiGr-1 (red, arrow), and skin capillaries are stained with high–molecular weight fluorescein 
isothiocyanate (FITC)–conjugated dextran (green). There is autofluorescence caused by hair bulbs (asterisks). 
Next, we experimentally wounded the skin of control non-diabetic mice, and checked 
them 3 days later. As shown in Figure 29, Gr-1+ neutrophils were present at the site of 
the ulcer, and the majority of them were in NETosis. In Figure 29 A, collagen structures 
visualization is generated by Second-Harmonic Generation signal (for more details, see 
SHIM in the “Multiphoton microscopy” chapter). Even though there were motion 
artifacts, mainly due to heart beat or breathing, we managed to visualize the wound bed 
at very high magnification. In Figure 29 D, a single neutrophil with decondensed 
chromatin can be seen in the process of casting NETs, as evidenced by the Sytox green 
staining in the close vicinity.  
 
 Figure 29 Neutrophils (Gr-1+, in red) infiltrated the wound bed. Nuclei are counterstained with cell-permeable 
Hoechst 33342 (in blue), whereas extracellular cell-free dsDNA (in green) is stained with the cell-
impermeable Sytox green dye. Scale bar 50 µm (A, B and C), 5 µm (D). 
 
We then validated imaging data through the analysis of tissue lysates by flow cytometry. 
Wounded skin contained larger amounts of Gr-1+ neutrophils, compared with intact 
skin. Furthermore, a greater percentage of neutrophils with citrullinated histones H3/4 
was found in wounded skin samples, compared with intact skin (Figure 30). 
 
Figure 30 A representative FACS plot showing that Gr-1+ neutrophils are very rare in the tissue lysate of the 
intact unwounded skin (A) and of wounded skin. 
 
In vitro treatment with PAD4 inhibitor 
Afterwards, we tested the mechanistic ability of NETosis to delay wound healing. Since 
NETosis is triggered by PAD4 activation, we used its pharmacological inhibitor Cl-
amidine. Neutrophils in which NOX-dependent NETosis was induced by PMA treatment 
ex vivo, were treated with Cl-amidine, and imaged for over 2 hours. As shown in Figure 
31, many control cells released DNA, while on the contrary the great majority of the Cl-
amidine-treated neutrophils still had lobulated nuclei.  
 Figure 31 The comparison of neutrophils with or without treatment of Cl-amidine, after 2 h of PMA-
stimulation: Sytox+ neutrophils were undergone in NETosis. 
 
We also wanted to check the effects of Cl-amidine on the ionomycin-induced NOX-
independent NETosis. Figure 32 shows representative FACS analysis for citrullinated 
histones H3/H4 (Cit-H3/4), indicating that Cl-amidine pretreatment was able to reduce 
the number of neutrophils undergoing NETosis. 
 
Figure 32 FACS staining for citrullinated histones H3/4 (Cit-H3/4) of mouse neutrophils stimulated with 
ionomycin with (orange) or without (blue) pretreatment with Cl-amidine with respect to the control 
condition (red). Magnification of the positive events with mean fluorescence intensity as well as the 
respective populations and frequencies is shown. 
Therefore, we demonstrated that Cl-amidine is able to reduce the induction of 
NETosis in vitro. 
 
 
Inhibition of NETosis rescue wound healing in diabetic mouse model 
The next step was to test the effect of NETosis inhibition in delaying wound healing. To 
this purpose, we administered Cl-amidine to diabetic mice, in the previously mentioned 
ulcer experimental model. In these mice, diabetes was induced by a single 
streptozotocin (STZ) injection (see the “Material and methods” section). PAD4 inhibition 
was able to reduce the number of neutrophils that underwent NETosis within the ulcer 
bed, compared with control diabetic mice (Figure 33). 
 
Figure 33 Representative FACS plots showing reduction of citrullinated H3/H4+ Gr-1+ neutrophils in the skin 
lysate of diabetic mice treated with Cl-amidine, compared to non-treated animals. 
Thus, also the in vivo PAD4 inhibition reduced the number of NETting neutrophils, as 
shown by the decrease in Gr-1+ Cit-H3/4+ cells in the wound of diabetic mice. 
 
We then monitored the effects on NETosis inhibition in vivo on wound healing in mice. 
Figure 34 shows our experimental scheme: mice with STZ-induced diabetes received Cl-
amidine treatment or vehicle (DMSO), and the control group non-diabetic mice, which 
were only injected with vehicle. 
 Figure 34 A schematic representation of the wound healing experiment in nondiabetic and streptozotocin 
(STZ) diabetic with (Cl-amidine) and without (DMSO) pretreatment. 
 
We followed the healing of the ulcers for 10 days: wound healing was delayed in 
diabetic mice compared with control mice, whereas pretreatment with Cl-amidine 
restored the normal wound healing in diabetic mice.  
 
Figure 35 Wound healing in nondiabetic, STZ diabetic, and diabetic mice treated with Cl-amidine. On the left, 
the graphic of the fold change in wound area over time (*P < 0.05 for diabetic vs. nondiabetic; #P < 0.05 for 
Cl-amidine–treated vs. nondiabetic). On the right, a representative digital imaging of wounds from the 3 
groups of mice up to day 9. 
 
Therefore, NETosis inhibition restored the normal healing of diabetic wounds.  
Discussion and Conclusions 
This work shows for the first time that an excess of NET proteins is associated with 
impaired wound healing and predicts a poor wound outcome in diabetic patients. In 
addition, neutrophils isolated from patients with DFU are prone to spontaneous NETosis 
but shows a defect in inducible NETosis. Two major types of NETosis have been 
described: (1) NOX-mediated NETosis, activated by PMA [36], and (2) NOX-independent 
NETosis, which has different signaling requirements [19], typically occurs in response to 
a S. aureus infection, and can be induced by Ca2+ ionophores (for example, ionomycin or 
a 23187).  
NET components, identified in NH wounds using a proteomic analysis (elastase, 
proteinase-3, NGAL and histones), were found at higher concentrations in the peripheral 
blood of DFU patients. This systemic NET spreading may be the result of leakage from 
the wound tissue or production by circulating neutrophils. The latter hypothesis is 
supported by evidence that neutrophils isolated from the blood of DFU patients are 
primed for spontaneous NETosis. Therefore, these data identify a systemic component 
of DFUs that can potentially damage remote tissues and contribute to an overall poor 
prognosis. 
Circulating cell free dsDNA is recognized as a “danger-associated molecular pattern” 
(DAMP) and can induce an exaggerated activation of innate immunity, whereby 
inflammation-induced DNA damage and DNA-induced inflammation form a vicious cycle. 
As a result, NETosis and NET-associated components can induce tissue damage. For 
instance, NETs have been shown to impair murine aortic endothelium dependent vaso-
relaxation and induced endothelial cell apoptosis [37]. On the other side, activated 
endothelial cells stimulate NETosis and are themselves damaged by NETs. Considering 
that endothelial dysfunction is considered the primum movens of atherosclerosis, it is 
easy to understand how NETosis can be linked to cardiovascular diseases.  
In vitro, we visualized typical NETosis features using immunofluorescence and TEM, but 
these methods provide variable results [38]. Since NETosis is not well known yet and, 
moreover, to avoid artifacts derived from fixed samples, we directly visualized in ex vivo 
neutrophils the typical features of NETosis phases. In order to dissect the steps of 
NETosis, we took advantage of a collaboration with prof. Mammano and Romanato and 
we deployed a custom two-photon microscope. This imaging setup allowed us to 
visualize neutrophils at high resolution. We were able to distinguish and characterize ex 
vivo NETosis process from other cell death programs. Here we described also two major 
types of NETosis: NADPH-oxidase (NOX) dependent, stimulated by PMA, and NADPH-
oxidase independent Ca2+-dependent, induced by Ca2+ ionophores. However, the 
understanding of signaling pathways governing NETs release remains not completely 
understood. 
Moreover, we also used this novel imaging setup for intravital microscopy. Our aim was 
to detect in vivo the NETosis process in the wound bed of our murine model. This 
method allows for a reliable view of this cell death: in vivo imaging is not subject to the 
biases of fixed-tissue imaging and NETting cells were identified by the typical features, 
characterized by in vitro experiments. This approach is so sensitive that permits the 
detection of single events of NETs release, within the ulcer.  
We cross-validated our live in vivo observations through cytofluorimetric analysis. FACS 
analysis shows that wounded skin contained larger amounts of Gr-1+ neutrophils, 
compared with intact skin. Furthermore, a greater percentage of neutrophils with 
citrullinated histones H3/4 was found in wounded skin samples, compared with intact 
skin. 
Experimental data in mouse indicate that NETosis occurs in the wound bed and may 
causatively contribute to poor wound healing in diabetic subjects. The increased NETosis 
and delayed wound healing in diabetes may be due to PAD4. Instead of PAD4 knock-out 
mice, we pharmacologically inhibited PAD4 activity with Cl-amidine and provided 
clinically transferrable evidence that NETosis machinery inhibition facilitates wound 
healing. These findings suggest that NETosis inhibition is a potential therapeutic strategy 
for wound healing acceleration in DFU patients. 
The ability of neutrophils to cast extracellular traps to kill bacteria has been known since 
more than 10 years, but the role of NETosis in health and disease has been fully 
recognized only recently. In particular, the involvement of this specific cell death in a 
multi-organ disease such as diabetes, could lead the way to new therapeutic horizons 
and new pathophysiological hypotheses. Chronic inflammation is not specific of 
metabolic disorders, but is also commonly associated with atherosclerosis and 
cardiovascular disease. Indeed, NETosis is beginning to be explored also in the setting of 
cardiovascular damage [39]. It has been already mentioned that NETosis and endothelial 
cell dysfunction can interact to promote vascular damage. Altogether, these recent data 
on the role played by NETosis in cardiovascular disease are supported by the 
observation that systemic levels of putative biomarkers of NETs release associate with 
the severity of atherosclerosis and predict future cardiovascular events [40]. Besides, an 
emerging role in atherosclerosis suggests that NETosis may also play a major role in 
acute myocardial infarction. A double-edged role for this biological process is arising, 
whereby NETs provide a defense against invasive infections, but can induce tissue injury, 
thrombosis, impair wound healing and promote cardiovascular disease at the same 
time. The finely tuned balance required to protect the human body from 
microorganisms, yet avoiding self-damage, seems to be lost in diabetes. This new 
perspective on NETosis as a contributor to hyperglycemia-mediated end-organ damage 
provides for the first time a comprehensive explanation for the tremendous 
susceptibility of diabetic patients to severe infections and worse infection-related 
outcomes. 
As a future perspective, we are willing to explore the role of NETosis on retinopathy, 
which is a frequent complication caused by diabetes among the macrovascular and 
microvascular disorders. The mechanisms leading to the neurodegeneration of the 
retina in diabetic patients include: low-grade inflammatory process, oxidative stress, 
activation of polymorphonuclear neutrophils, glutamate excitotoxicity and imbalance in 
the neuroprotective factors [41]. These aspects suggest a possible role of NETosis also in 
diabetic retinopathy. 
In conclusion, this study in mice and humans strongly expands our knowledge of the role 
of NETosis in one of the most threatening diabetes complications: DFU. Our data 
demonstrate that diabetes causes an over-production of PAD4, which triggers the 
activation of neutrophils, making them, in turn, more prone to enter NETosis. Hence, 
NETs production is a key factor which delays wound healing in diabetic patients. In 
summary, PAD4 inhibition and cleavage of NETs by DNase 1 could be novel therapeutic 
approaches to wound resolution in diabetes.   
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